
### [MONDO:0016578](http://purl.obolibrary.org/obo/MONDO_0016578)
**Label:** mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies

**Subclasses:** [MONDO:0017338](http://purl.obolibrary.org/obo/MONDO_0017338) (fatal multiple mitochondrial dysfunctions syndrome), [MONDO:0014720](http://purl.obolibrary.org/obo/MONDO_0014720) (autosomal dominant optic atrophy plus syndrome), [MONDO:0013350](http://purl.obolibrary.org/obo/MONDO_0013350) (mitochondrial DNA depletion syndrome 4b), [MONDO:0017312](http://purl.obolibrary.org/obo/MONDO_0017312) (Perrault syndrome), [MONDO:0018121](http://purl.obolibrary.org/obo/MONDO_0018121) (mitochondrial DNA maintenance syndrome), [MONDO:0008003](http://purl.obolibrary.org/obo/MONDO_0008003) (autosomal dominant progressive external ophthalmoplegia), [MONDO:0016808](http://purl.obolibrary.org/obo/MONDO_0016808) (mitochondrial DNA depletion syndrome, hepatocerebral form), [MONDO:0017718](http://purl.obolibrary.org/obo/MONDO_0017718) (mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes), [MONDO:0016804](http://purl.obolibrary.org/obo/MONDO_0016804) (exercise intolerance with lactic acidosis), [MONDO:0011835](http://purl.obolibrary.org/obo/MONDO_0011835) (sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome), [MONDO:0016797](http://purl.obolibrary.org/obo/MONDO_0016797) (multiple mitochondrial DNA deletion syndrome), [MONDO:0016796](http://purl.obolibrary.org/obo/MONDO_0016796) (mitochondrial DNA depletion syndrome, encephalomyopathic form), [MONDO:0011283](http://purl.obolibrary.org/obo/MONDO_0011283) (mitochondrial DNA depletion syndrome 1), [MONDO:0015487](http://purl.obolibrary.org/obo/MONDO_0015487) (fatal infantile encephalocardiomyopathy), [MONDO:0016799](http://purl.obolibrary.org/obo/MONDO_0016799) (mitochondrial oxidative phosphorylation disorder with no known mechanism), [MONDO:0016810](http://purl.obolibrary.org/obo/MONDO_0016810) (autosomal recessive progressive external ophthalmoplegia), [MONDO:0016798](http://purl.obolibrary.org/obo/MONDO_0016798) (ataxia neuropathy spectrum), [MONDO:0018337](http://purl.obolibrary.org/obo/MONDO_0018337) (severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency), [MONDO:0018158](http://purl.obolibrary.org/obo/MONDO_0018158) (mitochondrial DNA depletion syndrome), [MONDO:0010892](http://purl.obolibrary.org/obo/MONDO_0010892) (mitochondrial myopathy and sideroblastic anemia), [MONDO:0018157](http://purl.obolibrary.org/obo/MONDO_0018157) (mitochondrial disorder due to a defect in mitochondrial protein synthesis), [MONDO:0012792](http://purl.obolibrary.org/obo/MONDO_0012792) (mitochondrial DNA depletion syndrome 8a), [MONDO:0008134](http://purl.obolibrary.org/obo/MONDO_0008134) (autosomal dominant optic atrophy, classic form), [MONDO:0009723](http://purl.obolibrary.org/obo/MONDO_0009723) (Leigh syndrome), [MONDO:0018151](http://purl.obolibrary.org/obo/MONDO_0018151) (coenzyme Q10 deficiency), [MONDO:0016816](http://purl.obolibrary.org/obo/MONDO_0016816) (Leigh syndrome with nephrotic syndrome), [MONDO:0016815](http://purl.obolibrary.org/obo/MONDO_0016815) (Leigh syndrome with leukodystrophy), [MONDO:0018859](http://purl.obolibrary.org/obo/MONDO_0018859) (Leigh disease), 

**Corr. equiv. classes:** [OMIM:600462](http://purl.obolibrary.org/obo/OMIM_600462), [OMIM:157640](http://purl.obolibrary.org/obo/OMIM_157640), [OMIM:607459](http://purl.obolibrary.org/obo/OMIM_607459), [Orphanet:255235](http://www.orpha.net/ORDO/Orphanet_255235), [Orphanet:254886](http://www.orpha.net/ORDO/Orphanet_254886), [Orphanet:254822](http://www.orpha.net/ORDO/Orphanet_254822), [Orphanet:254843](http://www.orpha.net/ORDO/Orphanet_254843), [Orphanet:397593](http://www.orpha.net/ORDO/Orphanet_397593), [OMIM:612075](http://purl.obolibrary.org/obo/OMIM_612075), [Orphanet:254803](http://www.orpha.net/ORDO/Orphanet_254803), [Orphanet:254818](http://www.orpha.net/ORDO/Orphanet_254818), [OMIM:613662](http://purl.obolibrary.org/obo/OMIM_613662), [Orphanet:35698](http://www.orpha.net/ORDO/Orphanet_35698), [Orphanet:35696](http://www.orpha.net/ORDO/Orphanet_35696), [Orphanet:352456](http://www.orpha.net/ORDO/Orphanet_352456), [OMIM:256000](http://purl.obolibrary.org/obo/OMIM_256000), [Orphanet:1215](http://www.orpha.net/ORDO/Orphanet_1215), [Orphanet:255241](http://www.orpha.net/ORDO/Orphanet_255241), [Orphanet:98673](http://www.orpha.net/ORDO/Orphanet_98673), [Orphanet:254871](http://www.orpha.net/ORDO/Orphanet_254871), [Orphanet:254892](http://www.orpha.net/ORDO/Orphanet_254892), [Orphanet:35656](http://www.orpha.net/ORDO/Orphanet_35656), [Orphanet:255249](http://www.orpha.net/ORDO/Orphanet_255249), [Orphanet:309136](http://www.orpha.net/ORDO/Orphanet_309136), [Orphanet:289573](http://www.orpha.net/ORDO/Orphanet_289573), [Orphanet:2855](http://www.orpha.net/ORDO/Orphanet_2855), [Orphanet:254807](http://www.orpha.net/ORDO/Orphanet_254807), [OMIM:616648](http://purl.obolibrary.org/obo/OMIM_616648), [Orphanet:1561](http://www.orpha.net/ORDO/Orphanet_1561), [Orphanet:70595](http://www.orpha.net/ORDO/Orphanet_70595), [Orphanet:506](http://www.orpha.net/ORDO/Orphanet_506), [OMIM:165500](http://purl.obolibrary.org/obo/OMIM_165500), [Orphanet:2598](http://www.orpha.net/ORDO/Orphanet_2598), [OMIM:603041](http://purl.obolibrary.org/obo/OMIM_603041), 

**Class expressions from DL-Learner:**

- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 24.80%
- [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 24.26%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 24.08%
- Thing 24.07%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 24.07%
- [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 22.44%
- [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 22.17%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 21.91%
- [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 21.47%
- [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 21.32%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 21.13%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 20.72%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 20.55%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) 19.98%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 19.68%


